FETAL BOVINE SERUM MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)
Global fetal bovine serum market is estimated to be valued at USD 1.86 Bn in 2024 and is expected to exhibit a CAGR of 13.6% during the forecast period (2024-2031). Fetal bovine serum is an important cell culture media supplement used in scientific research and various medical processes. It is derived from fetal blood cells obtained from fetal blood collected from slaughtered pregnant cattle around 6 months of gestation. Fetal bovine serum (FBS) contains various growth factors, proteins, attachment factors, and vitamins essential for cell survival, growth, and proliferation. The increasing demand for biopharmaceuticals and rising focus on cell-based research is driving the growth of the fetal bovine serum market globally.
Market Dynamics:
The global fetal bovine serum market growth is driven by the rising demand for biopharmaceuticals and increasing research activities in life science industries. Biopharmaceutical production heavily relies on fetal bovine serum for growing and maintaining optimal cell culture conditions. Rising prevalence of chronic diseases is propelling the demand for new drug development which requires extensive research activities utilizing fetal bovine serum. However, price fluctuations in cattle farming and ethical concerns regarding animal welfare practices could hamper the market growth. Also, a shift towards serum-free and xeno-free cell culture mediums presents challenges to the fetal bovine serum market. Nonetheless, the growing focus on personalized medicine, regenerative therapies, and stem cell research are expected to present significant growth opportunities over the forecast period.
Key Features of the Study:
- This report provides in-depth analysis of the global fetal bovine serum market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global fetal bovine serum market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Merck KGaA, Thermo Fisher Scientific Inc., HiMedia Laboratories, Bio-Techne, PAN-Biotech, Atlas Biologicals, Inc., Rocky Mountain Biologicals, Cytiva, Sartorius AG, and SeraCare Life Sciences
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global fetal bovine serum market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fetal bovine serum market
Market Segmentation
Market Segmentation
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
